Related Experiment Video
Updated: Feb 22, 2026

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
Efficacy and safety of instantaneous wave-free ratio in patients undergoing coronary revascularisation: protocol for
Joey S W Kwong1, Sheyu Li2, Wan-Jie Gu3
1Department of Health Policy, National Center for Child Health and Development, Tokyo, Japan.
Insights
This systematic review protocol outlines an investigation into the instantaneous wave-free ratio (iFR) for guiding coronary revascularisation. It aims to synthesize evidence on iFR
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Diagnostic Imaging
Background:
- Accurate selection of coronary lesions for revascularisation is crucial for managing symptoms and improving outcomes in coronary artery disease patients.
- The instantaneous wave-free ratio (iFR) is a novel index for assessing coronary stenosis severity without requiring pharmacological vasodilation.
- Emerging evidence supports the effectiveness of iFR-guided revascularisation strategies.
Purpose of the Study:
- To conduct a systematic review of randomised controlled trials and controlled observational studies on iFR-guided coronary revascularisation.
- To evaluate the diagnostic accuracy and clinical effectiveness of iFR compared to other methods in guiding revascularisation decisions.
- To synthesize current evidence regarding the impact of iFR on patient outcomes and resource utilization.
Main Methods:
- Systematic search of electronic databases (MEDLINE, Embase, Cochrane) and ClinicalTrials.gov for relevant studies.
- Inclusion of randomised controlled trials and controlled observational studies adhering to predefined eligibility criteria.
- Data extraction by two independent reviewers, risk of bias assessment using validated tools, and meta-analysis using Review Manager software, adhering to PRISMA guidelines.
Main Results:
- This section will present the synthesized findings from the included studies.
- Quantitative and qualitative analyses will be performed to assess the efficacy and safety of iFR-guided revascularisation.
- Results will be presented in accordance with the PRISMA statement for systematic reviews.
Conclusions:
- The systematic review will provide a comprehensive assessment of the evidence for iFR-guided coronary revascularisation.
- Findings will inform clinical practice guidelines and future research directions in interventional cardiology.
- The review aims to clarify the role of iFR in optimising patient selection for revascularisation procedures.
Introduction:
Effective selection of coronary lesions for revascularisation is pivotal in the management of symptoms and adverse outcomes in patients with coronary artery disease. Recently, instantaneous 'wave-free' ratio (iFR) has been proposed as a new diagnostic index for assessing the severity of coronary stenoses without the need of pharmacological vasodilation. Evidence of the effectiveness of iFR-guided revascularisation is emerging and a systematic review is warranted.
Methods And Analysis:
This is a protocol for a systematic review of randomised controlled trials and controlled observational studies. Electronic sources including MEDLINE via Ovid, Embase, Cochrane databases and ClinicalTrials.gov will be searched for potentially eligible studies investigating the effects of iFR-guided strategy in patients undergoing coronary revascularisation. Studies will be selected against transparent eligibility criteria and data will be extracted using a prestandardised data collection form by two independent authors. Risk of bias in included studies and overall quality of evidence will be assessed using validated methodological tools. Meta-analysis will be performed using the Review Manager software. Our systematic review will be performed according to the guidance from the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.
Ethics And Dissemination:
Ethics approval is not required. Results of the systematic review will be disseminated as conference proceedings and peer-reviewed journal publication.
Trial Registration Number:
This protocol is registered in the International Prospective Register of Systematic Reviews (PROSPERO), registration number CRD42017065460.
More Related Videos
06:32Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care